Acute radiation dermatitis (ARD)-;characterized by red, sore, itchy or peeling skin-;affects up to 95% of people undergoing radiation treatment for cancer.
Study aimed to test the antibacterial and cytotoxic effects of bee venom-loaded chitosan nanoparticles (BV-loaded CS-NPs) against Staphylococcus aureus. The results showed that BV-loaded CS-NPs had enhanced antibacterial activity and minimal cytotoxicity, making it a promising antibiotic alternative.
A new bioengineered drug candidate demonstrated superior performance to a standard antibiotic at treating mice infected with Staphylococcus aureus, according to results from early testing published April 24 in Cell Host & Microbe.
Researchers at NYU Grossman School of Medicine and Janssen Biotech, Inc. have shown in early tests that a bioengineered drug candidate can counter infection with Staphylococcus aureus – a bacterial species widely resistant to antibiotics and a major cause of death in hospitalized patients.